Ibrance

$15.00

Description

Ibrance is a drug for the treatment of HR-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.

Reviews

There are no reviews yet.

Be the first to review “Ibrance”

Your email address will not be published. Required fields are marked *